Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva Is at Center of Drug Price-Fixing Case Filed by States - Bloomberg
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Israeli pharmaceutical company donating millions of doses of potential coronavirus drug to the U.S.
The Difficulties of Cloning a CEO - Bloomberg
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva Wins Ruling Tossing $235 Million Glaxo Drug Verdict - Bloomberg
Teva Analysts Say Migraine Drug Approval Gives Needed Relief - Bloomberg
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - Bloomberg
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - BNN Bloomberg
Teva's Adderall Shortage Seen Continuing Into March (TEVA) - Bloomberg
Teva to Pay $85 Million Settlement in Oklahoma Opioid Case - Bloomberg
Teva stock drops after conspiracy allegations on hiking drug prices
Activist Investor Jana Partners Takes Stake in Teva, Report Says | Ctech
Future Teva CEO Seeks to 'Formulate Clear Strategy' - YouTube
Teva Sees Adderall Supply Delays Continuing for 2-3 Months (1)
Actavis CEO: Teva-Mylan deal could be "value-destroying" - Globes
Teva CEO Says Drugmaker Will Fight U.S. Price-Fixing Charges (2)
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - BNN Bloomberg
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Adderall Shortages Spread to 4 Pharmaceutical Companies Including Teva, Novartis - Bloomberg
